u/sanne_laurent

Fasting or postprandial?

Keeping a log, and what to put in it.

Agreed, with the caveat that "usually settles" is not "always settles" and the exceptions should still get asked about properly.

fibre and water before you buy anything to fix it

This is the shape almost everybody here describes, and it is the single most reassuring thing in the thread.

the interesting data is the combination, not the monotherapy

sulphur burps are unpleasant and they are not dangerous

Appetite change and weight change are different measurements on different timescales. The first is usually noticed first and the second lags it.

Correction: that was clearance time, not carrier time. The lane table separates them for exactly this reason.

Packaging is assessable on arrival with no equipment: rigid outer, no movement inside, the cold element sized to the transit rather than to the box.

Push back: one sensor reading is not a data point worth acting on, especially in the first day of wear.

Ordered from the warehouse in Ireland instead of origin and the whole customs question disappeared. 14 days, door to door.

Median transit is the useful statistic. The minimum is a story about one shipment and the mean is dragged around by a single hold.

A quoted lead time is a commitment you can evaluate. Measuring quoted against actual across several orders tells you more about an operation than the raw speed does.

sulphur burps for the first eight days after each step, then nothing, every single time. Predictable enough that I started planning my week around it.

Most of the common complaints trace back to slowed gastric emptying — early fullness, reflux, nausea after a large or fatty meal. That is also why meal size and speed change the experience more than anything else.

Sent a vial to VendorInvestigate because there was almost nothing on file for this compound. 97.6% against a claimed 97.0%, and I posted it because the log needs entries.

Correcting myself upthread: I gave the 92-week figure and the paper reports 43 weeks.

Correction: that is the combination programme, not the monotherapy readout. Different arms, different numbers.

write down when it starts and stops, the pattern is the useful part

Severe or persistent abdominal pain sits outside the pattern this board can usefully discuss.

ayesha_radich is right about the timing. The day-of-week pattern is the diagnostic bit, not the severity.

Nothing in this thread is medical advice, including this comment. I am describing a mechanism, not telling anybody what to do about their own week.

Asked what a COA was in my first week. Somebody linked the explainer and I have been reading them ever since.

if it is severe or persistent that is a clinician question, not a board question

Small fix — that was the cardiovascular outcomes trial, so weight was a secondary endpoint and the population was different.

search first, but a repeat question is not a crime

A1c reflects average glycaemia over roughly the preceding three months, weighted towards the most recent weeks. It cannot show variability and it lags any change you make.

How long after a step up did this start?

mikkel_kimani is right about the timing. The day-of-week pattern is the diagnostic bit, not the severity.

The evidence standard on the vendor boards requires a document, a date or a named service behind any claim about a supplier. It is what makes those threads worth reading years later.

phase 2 finds a dose, phase 3 measures the effect

Push back: the ranking is not hiding anything. The formula is published and you can reproduce the ordering.

the co-agonism argument is about complementary mechanisms

Titration is a tolerance ladder. Each step exists so the gastrointestinal effects settle before the next increase, which is why the intervals are what they are.

sulphur burps are unpleasant and they are not dangerous

Appetite change and weight change are different measurements on different timescales. The first is usually noticed first and the second lags it.

the median is more useful than the fastest anybody ever got

Concentration is mass over volume, and a U-100 syringe reads 100 units per millilitre. Those two facts are the whole of the arithmetic this board keeps explaining.

Incretin-based agents stimulate insulin secretion in a glucose-dependent manner, which is why hypoglycaemia risk with them alone is low.

This is the distinction that resolves most of the confusion here — average versus shape.

Pushback: you changed the dose, the meal timing and the training in the same fortnight, so the attribution is guesswork.

The fatigue turned out to be that I was eating about a third of what I thought I was. Tracked it for a week and the mystery evaporated.

Correction: that is the combination programme, not the monotherapy readout. Different arms, different numbers.

this is a less-travelled board and the evidence base shows it